Related Experiment Video
Updated: Aug 24, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
E207K mutation of low-density lipoprotein receptor in familial hypercholesterolemia
Der-Yan Tai1, Guey-Jen Lee Chen, Anli Tso
1Department of Internal Medicine, Wei-Gong Memorial Hospital, Tou Fen, Miaoli, Taiwan.
Insights
This study identifies a genetic mutation causing familial hypercholesterolemia in a family, leading to premature coronary artery disease. Early detection of this low-density lipoprotein receptor mutation enables timely treatment to prevent heart disease.
Area of Science:
- Genetics
- Cardiology
- Biochemistry
Background:
- Familial hypercholesterolemia (HeFH) is an inherited disorder characterized by high LDL cholesterol levels.
- Premature coronary artery disease (CAD) is a significant complication of untreated HeFH.
- Genetic mutations in the low-density lipoprotein receptor (LDLR) gene are a common cause of HeFH.
Observation:
- A 36-year-old man presented with premature CAD and heterozygous familial hypercholesterolemia (HeFH).
- Hypercholesterolemia was prevalent in his mother, wife, and three children.
- Genetic analysis identified a specific G to A substitution (c.682G>A) in the LDLR gene.
Findings:
- The identified mutation, Glu(207) to Lys (E207K), was located in the ligand-binding domain of the LDLR.
- This E207K mutation was present in the affected family members, inherited from the mother and passed to the children.
- The proband's wife did not carry this specific LDLR mutation, despite having hypercholesterolemia.
Implications:
- The genetic identification of the E207K LDLR mutation confirms the cause of HeFH in this family.
- Early diagnosis through genetic testing allows for targeted interventions.
- Prompt treatment can mitigate the risk of premature cardiovascular events like CAD.
Abstract:
We report a case of heterozygous familial hypercholesterolemia (HeFH) in a 36-year-old man with premature coronary artery disease (CAD). Hypercholesterolemia was found in family members including his mother, wife and all 3 of his children (2 boys aged 6 and 3 years, 1 girl aged 4 years). Genetic analysis revealed a G-->A substitution at nucleotide 682, resulting in Glu(207) to Lys (E207K) mutation of the ligand-binding domain of the low-density lipoprotein receptor (LDLR) of all the family members with hypercholesterolemia except for the proband's wife. Genetic study showed that this mutation was inherited from the proband's mother then transmitted to all 3 children. Detection of this mutation identifies the cause of hypercholesterolemia and allows appropriate early treatment to prevent premature CAD.
Related Concept Videos
Lipid Catabolism
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Receptor-mediated Endocytosis
Pharmacogenomics: Identification of New Drug Targets
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid Digestion

